Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer.
Saved in:
| Title: | Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer. |
|---|---|
| Authors: | Yılmaz, Feride1 (AUTHOR) doktorferide@gmail.com, Yaşar, Serkan1 (AUTHOR), Tatar, Ömer Denizhan2 (AUTHOR), Yıldırım, Hasan Çağrı3 (AUTHOR), Güven, Deniz Can4 (AUTHOR), Akyıldız, Arif1 (AUTHOR), Chalabiyev, Elvin1 (AUTHOR), Aktaş, Burak Yasin1 (AUTHOR), Arık, Zafer1 (AUTHOR), Erman, Mustafa1 (AUTHOR) |
| Source: | BMC Cancer. 10/1/2024, Vol. 24 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 180038320 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Yılmaz%2C+Feride%22">Yılmaz, Feride</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> doktorferide@gmail.com</i><br /><searchLink fieldCode="AR" term="%22Yaşar%2C+Serkan%22">Yaşar, Serkan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tatar%2C+Ömer+Denizhan%22">Tatar, Ömer Denizhan</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yıldırım%2C+Hasan+Çağrı%22">Yıldırım, Hasan Çağrı</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Güven%2C+Deniz+Can%22">Güven, Deniz Can</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Akyıldız%2C+Arif%22">Akyıldız, Arif</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chalabiyev%2C+Elvin%22">Chalabiyev, Elvin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aktaş%2C+Burak+Yasin%22">Aktaş, Burak Yasin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Arık%2C+Zafer%22">Arık, Zafer</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Erman%2C+Mustafa%22">Erman, Mustafa</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 10/1/2024, Vol. 24 Issue 1, p1-11. 11p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=180038320 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-024-12935-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 1 Titles: – TitleFull: Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yılmaz, Feride – PersonEntity: Name: NameFull: Yaşar, Serkan – PersonEntity: Name: NameFull: Tatar, Ömer Denizhan – PersonEntity: Name: NameFull: Yıldırım, Hasan Çağrı – PersonEntity: Name: NameFull: Güven, Deniz Can – PersonEntity: Name: NameFull: Akyıldız, Arif – PersonEntity: Name: NameFull: Chalabiyev, Elvin – PersonEntity: Name: NameFull: Aktaş, Burak Yasin – PersonEntity: Name: NameFull: Arık, Zafer – PersonEntity: Name: NameFull: Erman, Mustafa IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 10/1/2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 14712407 Numbering: – Type: volume Value: 24 – Type: issue Value: 1 Titles: – TitleFull: BMC Cancer Type: main |
| ResultId | 1 |